Gold Nanocrystals Show Promise in MS and PD Treatment
Phase two clinical trials at UT Southwestern Medical Center have shown that gold nanocrystals could potentially reverse and improve neurological issues in patients with Multiple Sclerosis (MS) and Parkinson’s Disease (PD). This innovative treatment, highlighted in the Journal of Nanobiotechnology, showcases significant functional improvements and could pave the way for new therapies for neurodegenerative diseases. (Sources: utsouthwestern.edu, jnanobiotechnology.biomedcentral.com, utswmed.org)
Cresomycin: A New Hope Against Antibiotic-Resistant Superbugs
Research introduced a new drug, cresomycin, effective against antibiotic-resistant bacteria in animal tests. Published in Science, this development addresses the growing problem of antimicrobial resistance (AMR), showcasing cresomycin’s superior potency against deadly bacteria strains. This marks a crucial step in combating infections that resist existing drugs. (Source: ft.com)
Catherine J. Wu Wins Sjöberg Prize for Cancer Vaccine Research
Catherine J. Wu of Dana-Farber Cancer Institute has been awarded the Sjöberg Prize for her significant contributions to personalized cancer vaccine research. Her work, crucial for initiating clinical trials for melanoma, pancreatic, and lung cancer vaccines, underscores the potential for immune system-based treatments tailored to individual tumors. (Source: kva.se)
Breakthrough in Drug Interaction and Digestive Transport
MIT, Brigham and Women’s Hospital, and Duke University researchers have developed a strategy to identify how oral drugs exit the digestive system. This could lead to better patient treatment by preventing drug interactions and improving prescription guidelines. The research uncovers interactions between certain antibiotics and blood thinners, indicating a need for careful prescription practices. (Source: news.mit.edu)
CDC Updates COVID-19 Isolation Guidelines
The CDC has revised its COVID-19 guidelines, removing the mandatory five-day isolation for people testing positive. This decision aligns COVID-19 protocols with those for other respiratory illnesses, reflecting an adaptation to the current pandemic landscape and the widespread immunity achieved through vaccination and prior infections. (Source: washingtonpost.com)